Physician profile
Ashlyn E Monaghan
NPI 1265917256
$3,101.48
in general payments reported to CMS, 2019-2025
23 companies · $994 in 2025
The $994 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $674 · 2022: $363 · 2023: $658 · 2024: $412 · 2025: $994.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,064.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $567.84 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $563.96 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $527.96 | 2021-2025 | |
| Pfizer INC. | $241.51 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $177.64 | 2021-2025 | Xifaxan, Trulance |
| Merck Sharp & Dohme LLC | $150.65 | 2021-2023 | Belsomra |
| Glaxosmithkline, LLC. | $126.19 | 2021-2025 | Shingrix, Arexvy, Bexsero |
| Amgen INC. | $112.30 | 2023-2025 | Repatha, Otezla, Repatha |
| Biohaven Pharmaceutical Holding Company LTD. | $85.13 | 2022 | |
| Axsome Therapeutics, INC. | $78.14 | 2025 | Auvelity |
| Exact Sciences Corporation | $71.38 | 2023-2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $68.89 | 2023-2025 | Spravato |
| Organon LLC | $65.96 | 2023-2024 | Nexplanon |
| Astrazeneca Pharmaceuticals LP | $59.87 | 2021-2025 | Breztri, Airsupra |
| Takeda Pharmaceuticals U.S.A., INC. | $32.68 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $31.25 | 2025 | Veozah |
| Corium, LLC | $28.96 | 2025 | Azstarys |
| Inspire Medical Systems, INC. | $25.44 | 2025 | Inspire |
| Shield Therapeutics INC | $22.09 | 2025 | |
| Dynavax Technologies Corporation | $20.24 | 2023 | Heplisav-B |
| Bayer Healthcare Pharmaceuticals INC. | $16.00 | 2022 | |
| Genentech USA, INC. | $14.30 | 2021 | |
| Cranial Technologies, INC | $13.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashlyn Monaghan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.